HAART

The EMEA’s Committee for Medicinal Products for Human Use ( CHMP ) reminds healthcare professionals that Baraclude ( Entecavir )...


Stopping antiretroviral therapy in HIV-infected patients from time to time could reduce the side effects and costs of the treatment. Though...


Combining aggressive HIV therapy and chemotherapy significantly improves the survival rates of HIV-positive men and women treated for lymphoma. A study...


A study on HIV patients who also had hepatitis B virus ( HBV ) found that better outcomes are possible...


Researchers from the University of Massachusetts and the University of Pennsylvania have shown that race/ethnicity is a predictor of plasma...


Roche has obtained the European marketing approval for new 500 mg formulation of Invirase ( Saquinavir ), an protease inhibitor...


A imaging study carried out at UCLA/University of Pittsburgh for the first time has showen the selective pattern of destruction...